ReviewJournal of hematology & oncology2016

EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer.

Shuhang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.